Trials / Completed
CompletedNCT01413997
Connective Tissue Motion Measure
Feasibility Study of Connective Tissue Motion Measure - a Biomarker for Perimuscular Connective Tissue Pathology.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 39 (actual)
- Sponsor
- Stromatec, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The goal of this project is to develop a biomarker - the Connective Tissue Motion Measure (CTMM) -quantifying the functional behavior of perimuscular connective tissues.
Detailed description
The differential motion between specific connective tissue strata will be measured during tissue displacement (linear oscillation) initiated by a computer-controlled needle stimulus tool (NST). The CTMM will be suitable as an outcome measure for mechanistic and clinical studies of CAM interventions. The CTMM also will potentially serve as a clinical diagnostic and treatment-monitoring tool for manual therapists, acupuncturists, and CAM clinicians interested in assessing the functional status of a patient's connective tissue.
Conditions
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2011-08-10
- Last updated
- 2011-08-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01413997. Inclusion in this directory is not an endorsement.